Cytochrome P450 2C19 681G > A polymorphism in coronary heart disease patients treated with clopidogrel in Chinese

被引：0
|
作者：
Tang, Xiaofang
Yuan, Jinqing
Yang, Yuejin
机构：
[1] Chinese Acad Med Sci, Key Lab Clin Trial Res Cardiovasc Drugs, Minist Hlth, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
[2] Peking Union Med Coll, Beijing 100037, Peoples R China
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [21] Effect of cytochrome P450 2C19 (CYP2C19) gene polymorphism and clopidogrel reactivity on long term prognosis of patients with coronary heart disease after PCI
    Hu, Cheng-Yan
    Wang, Yan-Ling
    Fan, Zhen-Xing
    Sun, Xi-Peng
    Wang, Shuai
    Liu, Zhi
    JOURNAL OF GERIATRIC CARDIOLOGY, 2024, 21 (01) : 90 - 103
  • [22] Effect of cytochrome P450 2C19(CYP2C19) gene polymorphism and clopidogrel reactivity on long term prognosis of patients with coronary heart disease after PCI
    Cheng-Yan HU
    Yan-Ling WANG
    Zhen-Xing FAN
    Xi-Peng SUN
    Shuai WANG
    Zhi LIU
    Journal of Geriatric Cardiology, 2024, 21 (01) : 90 - 103
  • [23] GENETIC POLYMORPHISM OF CYTOCHROME P450 (2C19) IN PATIENTS WITH RENAL TRANSPLANT
    Ciftci, Hayriye Senturk
    Tefik, Tzevat
    Turkmen, Aydin
    Nane, Ismet
    Oguz, Fatma Savran
    Aydin, Filiz
    TISSUE ANTIGENS, 2014, 84 (01): : 58 - 59
  • [24] Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
    F Sofi
    B Giusti
    R Marcucci
    A M Gori
    R Abbate
    G F Gensini
    The Pharmacogenomics Journal, 2011, 11 : 199 - 206
  • [25] Cytochrome P450 2C19☆2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
    Sofi, F.
    Giusti, B.
    Marcucci, R.
    Gori, A. M.
    Abbate, R.
    Gensini, G. F.
    PHARMACOGENOMICS JOURNAL, 2011, 11 (03): : 199 - 206
  • [26] Relationship between cytochrome P450 2C19 polymorphism and cardiovascular events in Indonesian patients with coronary artery disease
    Mappiare, M.
    Amir, M.
    Kabo, P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2017, 19 (0E) : E22 - E22
  • [27] Cytochrome P450 2C19 genotyping for clopidogrel response - the state of play
    Dick, R. J.
    Byron, K. A.
    Dear, A. E.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 7 - 8
  • [28] Cytochrome P450 2C19 polymorphism and cardiovascular recurrences in patients under clopidogrel treatment: a meta-analysis
    Sofi, F.
    Giusti, B.
    Gori, A.
    Marcucci, R.
    Abbate, R.
    Gensini, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 105 - 105
  • [29] Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
    Zeruesenay Desta
    Xiaojiong Zhao
    Jae-Gook Shin
    David A. Flockhart
    Clinical Pharmacokinetics, 2002, 41 : 913 - 958
  • [30] Cytochrome P450 2C19*2 polymorphism diminishes peri-interventional antiplatelet effect of clopidogrel in patients undergoing percutaneous coronary intervention
    Trenk, D.
    Hochholzer, W.
    Fromm, M. F.
    Chialda, L.
    Pahl, A.
    Neumann, F. -J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 14 - 14
12345